phase iia study, page-10

So just to clarify my previous post regarding the phase IIa trial, and apologies if I am stating the obvious, my impression has been that this trial was not about the extension of life but about the impact Cvac had on the cancer marker CA125.

This is due to the fact patients were in very late stages of the disease, with some passing away before they received any or all of the required treatments. The fact Cvac worked on these patients is significant due to the state of their immune systems due to chemotherapy etc etc.

I believe this is what has caused so much excitement amongst the scientists involved with Cvac.

Hope this helps.

Regards